Clinical Trials Browser

Phase 4 × INDUSTRY × Neoplasms × Clear all

NCT02584933 2026-02-03

Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study

Phase 4 Active not recruiting

Neoplasms

NCT07279935 2025-12-12

REVIVE

Phase 4 Not yet recruiting

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Site, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT00646945 2025-09-16

Study of the Efficacy of Kalinox® 170 Bar in Adult Oncology

Phase 4 Completed

Neoplasms, Pain

NCT05342883 2025-09-05

GESTALT

Phase 4 Active not recruiting

Glioblastoma, Glioma, Neoplasms

NCT05900908 2025-04-10

PATHWAyS

Phase 4 Withdrawn

Glioblastoma, Neoplasm Metastasis, Neoplasms, Recurrence

NCT01794793 2024-10-01

Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies

Phase 4 Completed

337 enrolled 8 charts

DermatologicEndocrineGenitourinaryNET

Acromegaly, Dumping Syndrome, Melanoma, Neoplasms, Pituitary Neoplasms, Prostatic Neoplasms, Neuroendocrine Tumors, Pituitary ACTH Hypersecretion

NCT00942968 2024-04-18

Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer

Phase 4 Completed

338 enrolled 21 charts

Neoplasms

NCT06055543 2023-09-26

Impact of a New Plant-based High-energy Oral Nutritional Supplement on Nutritional Outcomes in Malnourished Patients

Phase 4 Unknown

Acquired Immunodeficiency Syndrome, Neoplasms, Inflammatory Bowel Diseases, Pulmonary Disease, Chronic Obstructive, Malnutrition

NCT03333655 2022-08-12

Study to Explore the Mechanism of Acquired Immune Escape In Participants With Metastatic Cancer Progressing on CPI Therapy

Phase 4 Completed

Neoplasm Metastasis, Neoplasms

NCT01789281 2021-06-11

Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.

Phase 4 Completed

34 enrolled 8 charts

Carcinoid Tumor, Neoplasms, Neuroendocrine Tumors

NCT01990534 2021-04-09

A Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin Lymphoma

Phase 4 Completed

60 enrolled 21 charts

Hematologic Diseases, Hodgkin Disease, Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Recurrence, Lymphoma, B-Cell, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse

NCT00381095 2021-01-20

COPE

Phase 4 Terminated

152 enrolled 14 charts

Bone Neoplasms, Neoplasms, Pain, Intractable

NCT01739764 2021-01-07

An Extension (Rollover) Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Malignancies Previously Enrolled in an Antecedent Vemurafenib Protocol

Phase 4 Completed

215 enrolled 12 charts

Neoplasms

NCT01588184 2020-11-05

An Extension Study to Provide Continued Bevacizumab Therapy to Participants With Solid Tumors Who Were Previously Enrolled in a Roche/Genentech Sponsored Study

Phase 4 Completed

95 enrolled 15 charts

Neoplasms

NCT03176121 2020-03-18

STOP Pain

Phase 4 Completed

Cancer Pain, Neoplasms, Pain

NCT03176199 2020-03-18

A Study to Compare the Titration Efficacy and Safety of Control-released Oxycodone and Immediate-released Oxycodone in Patients With Moderate to Severe Cancer Pain

Phase 4 Completed

Cancer Pain, Neoplasms, Pain

NCT04261920 2020-03-09

Clinical Trial Scheme of Huangqi Guizhi Wuwu Decoction

Phase 4 Unknown

Neoplasms

NCT02301962 2019-12-16

Phase IV Panitumumab Study in Indian Subjects With Metastatic Colorectal Cancer

Phase 4 Unknown

Gastrointestinal

Neoplasms, Colorectal Neoplasms

NCT01201811 2019-12-05

Study of Azacitidine in Adult Taiwanese Subjects With Higher-Risk Myelodysplastic Syndromes (MDS)

Phase 4 Completed

44 enrolled 26 charts

Bone Marrow Diseases, Hematologic Diseases, Myelodysplastic Syndromes, Neoplasms, Pathologic Processes

NCT01525550 2019-07-30

A Study Of The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors

Phase 4 Completed

106 enrolled 26 charts

EndocrineGastrointestinalNET

Adenoma, Carcinoma, Neoplasms, Pancreatic Neoplasms, Neuroendocrine Tumors

NCT01743560 2019-07-18

4EVERUK

Phase 4 Completed

52 enrolled 16 charts

Breast Diseases, Breast Neoplasms, Neoplasms, Skin Diseases

NCT03831633 2019-02-06

Comparative Effectiveness of AKYNZEO® and Standard of Care (Including EMEND®) for the Prevention of Nausea and Vomiting (CINV) in Cancer Patients

Phase 4 Unknown

Neoplasms

NCT01636947 2018-09-25

KMEC

Phase 4 Completed

494 enrolled 14 charts

Nausea, Neoplasms, Vomiting

NCT01313780 2017-12-22

TOP

Phase 4 Completed

128 enrolled 8 charts

Cancer Pain, Neoplasms

NCT00198276 2017-10-03

Study Using the MedPulser Electroporation System With Bleomycin to Treat Cutaneous and Subcutaneous Cancer

Phase 4 Completed

Neoplasms

NCT00171964 2017-06-01

Efficacy and Tolerability of Zoledronic Acid With Radiotherapy in Pts With Advanced Osteolytic Bone Lesions

Phase 4 Completed

Neoplasm Metastasis, Neoplasms, Pain

NCT00684463 2017-05-16

Palonosetron in Moderately and Highly Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04935)(COMPLETED)

Phase 4 Completed

Nausea, Neoplasms, Vomiting

NCT00241111 2017-03-06

Assessment of the Efficacy, Tolerability and Pharmaco-economic Impact of Zoledronic Acid Treatment in Prostate Cancer With Bone Metastasis

Phase 4 Completed

Neoplasms

NCT00434317 2017-02-23

Assessment of Pain and Quality of Life in Breast and Prostate Cancer Patients With Bone Metastases

Phase 4 Completed

BreastGenitourinary

Breast Neoplasms, Neoplasm Metastasis, Neoplasms, Pain, Prostatic Neoplasms

NCT00495378 2016-12-20

RAPID-2. A Study to Evaluate the Effectiveness of Alternate Dosing of PROCRIT (Epoetin Alfa) in Maintaining Hemoglobin Levels in Patients With Chemotherapy Related Anemia

Phase 4 Terminated

Classical hematology

Anemia, Neoplasms

NCT01675531 2016-12-16

A Study to Assess the Efficacy and Safety of Oxycodone/Naloxone in Korean Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN)

Phase 4 Completed

73 enrolled 11 charts

Neoplasms

NCT01328054 2016-06-08

A Study in Cancer Patients to Evaluate the Effect of Lapatinib on the QTc Interval

Phase 4 Completed

58 enrolled 17 charts

Neoplasms

NCT00747916 2015-07-16

Safety, Efficacy, and Side Effects Study of Interventional Cryotherapy in the Pleural Space("ICE PLS")

Phase 4 Terminated

3 enrolled 6 charts

Lung Neoplasms, Neoplasms, Pleural Neoplasms

NCT00352859 2014-12-30

Phase IV Randomization to On-Going Treatment to Evaluate Sustained Sorafenib

Phase 4 Terminated

Carcinoma, Renal Cell, Neoplasms

NCT00771199 2014-09-17

An Efficacy and Safety Study of Low-dose Transdermal Therapeutic System (TTS)-Fentanyl D-Trans in Taiwan Participants With Cancer Pain

Phase 4 Completed

Cancer Pain, Neoplasms, Pain

NCT01968018 2013-10-23

A Study of Safety and Effectiveness of Ultracet in Patients With Chronic Cancer Pain

Phase 4 Completed

Neoplasms

NCT01648699 2013-10-11

Safety and Efficacy Study of Osmotic Release Oral System (OROS) Hydromorphone in Participants With Cancer Pain

Phase 4 Terminated

20 enrolled 9 charts

Neoplasms, Pain

NCT01006356 2013-08-08

An Efficacy and Safety Study of Hydromorphone Hydrochloride (HCl) Oral Osmotic System (OROS) in the Reduction of Breakthrough Pain Medication Frequency in Participants With Cancer

Phase 4 Completed

141 enrolled 13 charts

Neoplasms, Pain

NCT01107756 2012-10-05

Grano-Tax

Phase 4 Completed

Neoplasms

NCT01318473 2012-10-03

ActiSight

Phase 4 Completed

Neoplasms

NCT01040884 2012-07-12

Safety And Accuracy Study Of The Actisight™ Needle Guidance System In Patients Undergoing CT-Guided Procedures

Phase 4 Completed

Neoplasms

NCT01205230 2012-05-22

VEG113971: An Open-Label Study of the Effects of Ketoconazole or Esomeprazole on Pazopanib PK

Phase 4 Completed

34 enrolled 17 charts

Neoplasms

NCT00894153 2012-04-09

p53 Gene Therapy for Head and Neck Malignant Tumors in Advanced Stage

Phase 4 Unknown

Neoplasms

NCT00902083 2012-04-09

rAd-p53

Phase 4 Unknown

Neoplasms

NCT00902122 2012-04-09

rAd-p53 Gene Therapy for Advanced Malignant Thyroid Tumors

Phase 4 Unknown

Neoplasms, Thyroid Diseases

NCT01394991 2012-04-05

A Safety Study of Epoetin Alfa in Patients With Cancer Who Have Chemotherapy-Related Anemia

Phase 4 Completed

504 enrolled 17 charts

Classical hematology

Anemia, Neoplasms

NCT00216541 2011-05-19

A Study of the Safety and Effectiveness of Epoetin Alfa on Hemoglobin Levels and Blood Transfusions in Cancer Patients Receiving Chemotherapy

Phase 4 Completed

Classical hematology

Anemia, Neoplasms

NCT00616135 2011-05-17

RESTORE-2

Phase 4 Completed

Breast Neoplasms, Carcinoma, Neoplasms, Carcinoma, Ductal, Breast

NCT00283465 2011-01-14

A Study of the Effectiveness and Safety of Treatment With Epoetin Alfa on Hemoglobin Levels, Red Blood Cell Transfusions, and Quality of Life in Patients With Cancer Receiving Platinum-containing Chemotherapy

Phase 4 Completed

Classical hematology

Anemia, Neoplasms

NCT00050635 2009-11-19

STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea

Phase 4 Completed

Gastrointestinal

Diarrhea, Neoplasms, Colorectal Neoplasms